Sedulo Group — Recent Moves (17 tracked, last 90 days)

Sedulo Group is a competitive intelligence (CI) and strategic advisory firm that has been highly active in the life sciences and pharmaceutical sectors, as evidenced by its recent moves. With 17 tracked moves since mid-June 2026, the company is aggressively expanding its thought leadership, product offerings, and industry presence.

Watching Sedulo Group now matters because it is not merely publishing content—it is systematically building a comprehensive CI ecosystem. From launching new assessment tools and frameworks to sponsoring major industry conferences and releasing targeted case studies, Sedulo Group is positioning itself as a central authority in the competitive intelligence space. Its recent activities signal a strategic push to influence how pharmaceutical and life sciences companies approach market intelligence, making it a key player to monitor for competitive dynamics.

Product and Framework Expansion: Sedulo Group is rapidly expanding its intellectual property and digital offerings. In mid-June 2026, it added new strategic decision frameworks to its digital template library and promoted its 'Gold' PPT framework for executive-ready intelligence reporting. This was followed by the launch of a Strategic Intelligence Maturity Assessment Tool in August 2026 and a framework for B2B Deal Desk implementation in late July. These moves indicate a shift from purely advisory services to scalable, productized tools that clients can adopt internally, signaling a move toward recurring revenue and broader market reach.

Thought Leadership and Content Marketing: The company is heavily investing in content to establish authority. It has released case studies across cybersecurity, diagnostics D2C, pharmaceutical BD scouting, and real-time oncology sales monitoring. It also promotes 'The Intelligence Exchange' newsletter for executive decision support and positions its custom research against generic benchmarking reports. This content engine supports its conference presence and survey initiatives, creating a flywheel of engagement and lead generation.

Conference and Community Engagement: Sedulo Group is making a significant push into industry events. It is the lead sponsor for the Pharma CI USA 2026 Conference and will present at Pharma CI Europe 2026. It also opened its 2026 Life Sciences Competitive Intelligence Survey in July. These moves are designed to place Sedulo Group at the center of the CI community, fostering networking, data collection, and brand visibility among key decision-makers.

Positioning and Validation: The company is actively shaping its market position. It is promoting counterintelligence auditing for defensive strategy and has received high-authority validation from Clarivate in a pharma feature. This external endorsement, combined with its own frameworks and tools, helps Sedulo Group differentiate itself from generic benchmarking providers and position as a premium, strategic partner.

What to watch: Monitor how Sedulo Group converts its conference sponsorships and survey data into new client engagements and proprietary benchmarks. Also watch for further product launches that deepen its toolset, and whether it expands beyond life sciences into other verticals given its cross-industry case studies. Its ability to maintain momentum and convert thought leadership into market share will be key indicators of its strategic success.